MedPath

Butalbital, Acetaminophen, and Caffeine

Butalbital,Acetaminophen, andCaffeine Tablets, USP

Approved
Approval ID

fef4844c-2b44-4e5c-9da3-e5b2214c9e8d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 20, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Butalbital, Acetaminophen, and Caffeine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-209
Application NumberANDA089718
Product Classification
M
Marketing Category
C73584
G
Generic Name
Butalbital, Acetaminophen, and Caffeine
Product Specifications
Route of AdministrationORAL
Effective DateAugust 7, 2008
FDA Product Classification

INGREDIENTS (7)

ButalbitalActive
Quantity: 50 mg in 1 1
Code: KHS0AZ4JVK
Classification: ACTIB
AcetaminophenActive
Quantity: 325 mg in 1 1
Code: 362O9ITL9D
Classification: ACTIB
CaffeineActive
Quantity: 40 mg in 1 1
Code: 3G6A5W338E
Classification: ACTIB
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
Colloidal Silicon DioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Butalbital, Acetaminophen, and Caffeine - FDA Drug Approval Details